HRS Guidelines Bundle (free trial)

Evaluation and Management of Arrhythmic Risk in Neuromuscular Disorders

Heart Rhythm Society GUIDELINES Apps brought to you free pf charge, courtesy of Guideline Central. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1499527

Contents of this Issue

Navigation

Page 18 of 49

19 YES YES YES YES ICD concordant with patient goals of care and clinical status ICD concordant with patient goals of care and clinical status NO NO NO Pacemaker (1) Pacemaker (2a) ICD (2b) ICD (2b) a Patients with indications for pacemaker or ICD implantation, including CRT, based on recommendations from previously published guidelines are not represented in this flow diagram. b Physical examination, ECG, ambulatory ECG, and cardiac imaging (echocardiography or CMR) at diagnosis with periodic retesting. c e purpose of EP testing for risk stratification of sudden death is to assess integrity of AV conduction, in particular, the His-Purkinje system with measurement of the HV interval, as well as to determine inducibility of clinically significant VAs. A suggested stimulation protocol used in DM1 patients has been published,* and other protocols primarily used in patients with ischemic heart disease may also be useful. e discussion of device implantation should be carried out prior to EP testing to confirm the patient's preference and willingness to undergo CIED implantation. d Mild to moderate conduction disorder is defined as PR interval 200–240 ms and/or QRS duration 100–120 ms. e Noninvasive testing includes 12-lead ECG, telemetry recordings, ambulatory ECG, or insertable loop recorder. Colors correspond to the class of recommendation (COR) on pages 48–49. * Lazarus A, Varin J, Ounnoughene Z, et al. Circulation 1999;99:1041–1046.

Articles in this issue

Archives of this issue

view archives of HRS Guidelines Bundle (free trial) - Evaluation and Management of Arrhythmic Risk in Neuromuscular Disorders